Cellectis A/S (NASDAQ: CLLS) on Wednesday published an article in Nature Communications establishing circular single-stranded DNA (CssDNA) as a highly efficient non-viral DNA donor template for gene ...
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results